Advances towards licensure of a maternal vaccine for the prevention of invasive group B streptococcus disease in infants: a discussion of different approaches.

Female Humans Infant Infant, Newborn Infectious Disease Transmission, Vertical / prevention & control Pregnancy Pregnancy Complications, Infectious / microbiology Streptococcal Infections / prevention & control Streptococcal Vaccines Streptococcus agalactiae
GBS;invasive disease;infants;IAP;capsular polysaccharide;conjugate vaccine;maternal immunization;serocorrelate

Journal

Human vaccines & immunotherapeutics
ISSN: 2164-554X
Titre abrégé: Hum Vaccin Immunother
Pays: United States
ID NLM: 101572652

Informations de publication

Date de publication:
31 12 2022
Historique:
pubmed: 5 3 2022
medline: 15 4 2022
entrez: 4 3 2022
Statut: ppublish

Résumé

Group B streptococcus (

Identifiants

DOI: 10.1080/21645515.2022.2037350 PMID: 35240933 PMC: PMC9009955
pubmed: 35240933
doi: 10.1080/21645515.2022.2037350
pmc: PMC9009955
doi:

Substances chimiques

Streptococcal Vaccines 0

Types de publication

Journal Article Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2037350

Références

MMWR Recomm Rep. 2002 Aug 16;51(RR-11):1-22
pubmed: 12211284
N Engl J Med. 1976 Apr 1;294(14):753-6
pubmed: 768760
BMC Pediatr. 2015 Oct 01;15:143
pubmed: 26427955
Clin Infect Dis. 2017 Nov 06;65(suppl_2):S112-S124
pubmed: 29117328
Lancet Infect Dis. 2016 Aug;16(8):923-34
pubmed: 27139805
Lancet Infect Dis. 2021 Feb;21(2):263-274
pubmed: 32891191
Clin Infect Dis. 2016 Sep 15;63(6):746-753
pubmed: 27402816
Crit Rev Microbiol. 2020 May;46(3):253-269
pubmed: 32363979
Clin Infect Dis. 2017 Nov 13;65(11):1897-1904
pubmed: 29029127
Clin Dev Immunol. 2012;2012:985646
pubmed: 22235228
Clin Infect Dis. 2017 Nov 06;65(suppl_2):S200-S219
pubmed: 29117332
JAMA Pediatr. 2020 Jul 1;174(7):e200593
pubmed: 32364598
Vaccine. 2003 Jul 28;21(24):3468-72
pubmed: 12850362
Pediatrics. 2019 Aug;144(2):
pubmed: 31285392
Pediatrics. 2012 Jul;130(1):e8-15
pubmed: 22689869
J Infect Dis. 2001 Oct 15;184(8):1022-8
pubmed: 11574917
Pediatr Infect Dis J. 2008 Dec;27(12):1057-64
pubmed: 18989238
Vaccine. 2009 Jul 16;27(33):4452-6
pubmed: 19490960
Biometrics. 2001 Mar;57(1):135-42
pubmed: 11252588
Ann Epidemiol. 2007 Nov;17(11):854-62
pubmed: 17689259
Nature. 2019 Aug;572(7769):329-334
pubmed: 31367035
Vaccine. 2013 Aug 28;31 Suppl 4:D20-6
pubmed: 23219695
PLoS One. 2016 Apr 07;11(4):e0152524
pubmed: 27055184
Vaccine. 2013 Aug 28;31 Suppl 4:D31-42
pubmed: 23973345
J Infect Dis. 2014 Mar 1;209(5):781-8
pubmed: 24133184
Clin Infect Dis. 2021 Sep 7;73(5):e1170-e1180
pubmed: 33341870
PLoS One. 2011 Mar 21;6(3):e17861
pubmed: 21445302
Pediatr Infect Dis J. 2011 Sep;30(9):759-63
pubmed: 21540758
Clin Infect Dis. 2017 Nov 06;65(suppl_2):S152-S159
pubmed: 29117325
Clin Infect Dis. 2017 Nov 06;65(suppl_2):S160-S172
pubmed: 29117326
Antibiot Chemother (1971). 1985;35:267-80
pubmed: 3931544
Infect Immun. 1984 Sep;45(3):618-24
pubmed: 6381309
Clin Infect Dis. 2019 May 30;68(12):2079-2086
pubmed: 30281066
J Infect Dis. 1999 Jan;179(1):142-50
pubmed: 9841833
Clin Infect Dis. 2020 Jun 10;70(12):2570-2579
pubmed: 31394574
Infect Dis Obstet Gynecol. 2019 Feb 3;2019:5430493
pubmed: 30853787
N Engl J Med. 2011 May 26;364(21):2016-25
pubmed: 21612470
Infect Immun. 1992 Oct;60(10):3986-93
pubmed: 1398910
J Pediatr. 1973 Dec;83(6):919-25
pubmed: 4585831
Vaccine. 2003 Jul 4;21(23):3265-72
pubmed: 12804857
J Infect Dis. 2004 Mar 15;189(6):1103-12
pubmed: 14999615
Infect Immun. 1998 May;66(5):2186-92
pubmed: 9573106
J Clin Invest. 1996 Nov 15;98(10):2308-14
pubmed: 8941648
J Infect Dis. 2000 Oct;182(4):1129-38
pubmed: 10979909
Vaccine. 2015 Nov 25;33(47):6388-95
pubmed: 26314626
Front Immunol. 2017 Oct 13;8:1294
pubmed: 29163461
Clin Vaccine Immunol. 2010 Jul;17(7):1055-65
pubmed: 20463105
Vaccine. 2015 Nov 27;33(48):6793-9
pubmed: 26478200
N Engl J Med. 2009 Jun 18;360(25):2626-36
pubmed: 19535801
Vaccine. 2020 Oct 14;38(44):6930-6940
pubmed: 32883555
Lancet Infect Dis. 2017 Jul;17(7):e209-e222
pubmed: 28433704
Nat Rev Immunol. 2009 Mar;9(3):213-20
pubmed: 19214194
BJOG. 2013 Nov;120(12):1450-2
pubmed: 24118809
Clin Infect Dis. 2017 Nov 06;65(suppl_2):S133-S142
pubmed: 29117329
J Infect Dis. 2004 Sep 1;190(5):928-34
pubmed: 15295698
Obstet Gynecol. 2016 Feb;127(2):213-21
pubmed: 26942345
N Engl J Med. 1986 Jun 26;314(26):1665-9
pubmed: 3520319
MMWR Recomm Rep. 2010 Nov 19;59(RR-10):1-36
pubmed: 21088663
PLoS One. 2015 Apr 07;10(4):e0123014
pubmed: 25849416
Int J Biostat. 2008 Sep 29;4(1):Article 19
pubmed: 20231910
ACS Chem Biol. 2013 Aug 16;8(8):1653-63
pubmed: 23841819
J Pediatr. 1973 Apr;82(4):724-9
pubmed: 4735411
Vaccine. 2017 Dec 14;35(49 Pt B):6905-6914
pubmed: 29129451
J Infect Dis. 2019 Jun 5;220(1):105-115
pubmed: 30778554
Vaccine. 2013 Aug 28;31 Suppl 4:D3-6
pubmed: 23973344
PLoS One. 2016 Dec 30;11(12):e0169101
pubmed: 28036363

Auteurs

Judith Absalon (J)

Pfizer Vaccine Research & Development, Pearl River, NY, USA.

Raphael Simon (R)

Pfizer Vaccine Research & Development, Pearl River, NY, USA.

David Radley (D)

Pfizer Vaccine Research & Development, Pearl River, NY, USA.

Peter C Giardina (PC)

Pfizer Vaccine Research & Development, Pearl River, NY, USA.

Kenneth Koury (K)

Pfizer Vaccine Research & Development, Pearl River, NY, USA.

Kathrin U Jansen (KU)

Pfizer Vaccine Research & Development, Pearl River, NY, USA.

Annaliesa S Anderson (AS)

Pfizer Vaccine Research & Development, Pearl River, NY, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Advances towards licensure of a maternal...
questionsmedicales.fr › Personnes › Tranches d'âge › Nourrisson › Advances towards licensure of a maternal...
questionsmedicales.fr › Personnes › Tranches d'âge › Nourrisson › Nouveau-né › Advances towards licensure of a maternal...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Transmission de maladie infectieuse › Transmission verticale de maladie infectieuse › Advances towards licensure of a maternal...
questionsmedicales.fr › Phénomènes physiologiques des appareils urinaire et reproducteur › Phénomènes physiologiques de la reproduction › Reproduction › Grossesse › Advances towards licensure of a maternal...
questionsmedicales.fr › Maladies urogénitales › Maladies de l'appareil urogénital féminin et complications de la grossesse › Complications de la grossesse › Complications infectieuses de la grossesse › Advances towards licensure of a maternal...
questionsmedicales.fr › Infection › Infections bactériennes et mycoses › Infections bactériennes › Infections bactériennes à Gram positif › Infections à streptocoques › Advances towards licensure of a maternal...
questionsmedicales.fr › Mélanges complexes › Produits biologiques › Vaccins › Vaccins antibactériens › Vaccins antistreptococciques › Advances towards licensure of a maternal...
questionsmedicales.fr › Bactéries › Bactéries à Gram positif › Lactobacillales › Streptococcaceae › Streptococcus › Streptococcus agalactiae › Advances towards licensure of a maternal...